Literature DB >> 8099857

T cell receptor V beta repertoire in HIV-infection individuals: lack of evidence for selective V beta deletion.

V Boyer1, L R Smith, F Ferre, P Pezzoli, R J Trauger, F C Jensen, D J Carlo.   

Abstract

The gradual decline of CD4+ T lymphocytes in HIV-infected individuals culminates in the lethal immunosuppression of AIDS. The mechanism of CD4+ T cell loss is currently unknown, but has recently been suggested to occur as a result of an HIV-encoded superantigen which facilitates a selective deletion of T cells expressing specific V beta genes. To verify and extend such observations, peripheral blood leucocytes (PBL) from 15 HIV+ individuals, 10 of which had very low CD4 T cell counts (< 200/mm3), were analysed for T cell receptor (TCR) V beta gene expression. In contrast to a recent study, the results presented here fail to provide evidence that selective loss of V beta-bearing T cells occurs in HIV+ individuals. Furthermore, when PBL from HIV+ individuals were stimulated with Staphylococcal enterotoxin B (SEB), T cells expressing V beta subfamilies known to engage this superantigen were expanded, indicating that such cells were not deleted and were responsive to stimulation by a bacterial superantigen. Collectively, these data suggest that CD4 loss in HIV patients does not occur in a V beta-selective, superantigen-mediated fashion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099857      PMCID: PMC1554770          DOI: 10.1111/j.1365-2249.1993.tb03417.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  The human T cell receptor beta-chain gene complex contains at least 57 variable gene segments. Identification of six V beta genes in four new gene families.

Authors:  M A Robinson
Journal:  J Immunol       Date:  1991-06-15       Impact factor: 5.422

Review 2.  The polymerase chain reaction in an anemic mode: how to avoid cold oligodeoxyribonuclear fusion.

Authors:  K B Mullis
Journal:  PCR Methods Appl       Date:  1991-08

3.  Immune recognition. Mls: makes a little sense.

Authors:  C Janeway
Journal:  Nature       Date:  1991-02-07       Impact factor: 49.962

4.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

5.  Interaction of Staphylococcus aureus toxin "superantigens" with human T cells.

Authors:  Y W Choi; B Kotzin; L Herron; J Callahan; P Marrack; J Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

6.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 7.  The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.

Authors:  A S Fauci
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

Review 8.  Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis.

Authors:  J C Ameisen; A Capron
Journal:  Immunol Today       Date:  1991-04

9.  Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein.

Authors:  K W Wucherpfennig; K Ota; N Endo; J G Seidman; A Rosenzweig; H L Weiner; D A Hafler
Journal:  Science       Date:  1990-05-25       Impact factor: 47.728

10.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.

Authors:  A G Dalgleish; P C Beverley; P R Clapham; D H Crawford; M F Greaves; R A Weiss
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

View more
  9 in total

Review 1.  Study of the T cell receptor repertoire in viral immunodeficiency disease.

Authors:  C Ciurli; R P Sékaly; H Soudeyns
Journal:  Springer Semin Immunopathol       Date:  1996

2.  T cell receptor usage in patients with non-progressing HIV infection.

Authors:  M D Bodman-Smith; I Williams; R Johnstone; A Boylston; P M Lydyard; A Zumla
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

3.  Early increase of CD4+ CD45RA+ and CD4+ CD95- cells with conserved repertoire induced by anti-retroviral therapy in HIV-infected patients.

Authors:  G Silvestri; C Munoz-Calleja; P Bagnarelli; G Piedimonte; M Clementi; M Montroni
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

4.  HIV-1 infection impairs cell cycle progression of CD4(+) T cells without affecting early activation responses.

Authors:  S F Sieg; C V Harding; M M Lederman
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

5.  The Role of the Envelope Glycoprotein in the Depletion of T Helper Cells in Human Immunodeficiency Virus Infection.

Authors:  Christian Jassoy; Martin Heinkelein; Sieghart Sopper
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

Review 6.  Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions.

Authors:  N Chirmule; S Pahwa
Journal:  Microbiol Rev       Date:  1996-06

7.  Maintenance of CD4+ T cell TCR Vbeta repertoire heterogeneity is characteristic of apathogenic SIV infection in non-human primate model of AIDS.

Authors:  Pavel Bostik; Susan T Stephenson; Rebecca M Lynch; Adriana Cardona; Aftab A Ansari
Journal:  Virology       Date:  2007-09-21       Impact factor: 3.616

Review 8.  Superantigens and pseudosuperantigens of gram-positive cocci.

Authors:  B Fleischer; D Gerlach; A Fuhrmann; K H Schmidt
Journal:  Med Microbiol Immunol       Date:  1995-05       Impact factor: 3.402

9.  Human immunodeficiency virus 1 reservoir in CD4+ T cells is restricted to certain V beta subsets.

Authors:  D Dobrescu; S Kabak; K Mehta; C H Suh; A Asch; P U Cameron; A S Hodtsev; D N Posnett
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.